Cargando…
Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma
BACKGROUND: In a previous study utilizing mass spectrometry-based proteomics, we identified calcium-activated chloride channel regulator 1 (CLCA1) as a potential tumor suppressor in pancreatic cancer and the expression was inversely correlated with patient survival. The aim of the study was to furth...
Autores principales: | Hu, Dingyuan, Ansari, Daniel, Zhou, Qimin, Sasor, Agata, Hilmersson, Katarzyna Said, Bauden, Monika, Jiang, Yi, Andersson, Roland |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233502/ https://www.ncbi.nlm.nih.gov/pubmed/30419838 http://dx.doi.org/10.1186/s12885-018-5013-2 |
Ejemplares similares
-
Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2019) -
Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2018) -
YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling
por: Zhou, Qimin, et al.
Publicado: (2020) -
Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue
por: Zhou, Qimin, et al.
Publicado: (2019) -
Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma
por: Bauden, Monika, et al.
Publicado: (2017)